Arndt Vogel

机构：University Health Network, Toronto General Hospital, Princess Margaret Cancer Centre, Medizinische Hochschule Hannover · ORCID：0000-0003-0560-5538

发表论文 761 篇 · 总被引 38400 次 · h-index 82

代表论文

• Cholangiocarcinoma 2026: status quo, unmet needs and priorities (2025 · Nature Reviews Gastroenterology & Hepatology · 被引 56)
• Pembrolizumab Plus Chemotherapy Versus Chemotherapy as Perioperative Therapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer: Final Analysis of the Randomized, Phase III KEYNOTE-585 Study (2025 · Journal of Clinical Oncology · 被引 39)
• Navigating second-line therapy after immunotherapy in advanced HCC☆ (2025 · JHEP Reports · 被引 7)
• Genomic pathway alterations and their prognostic impact in biliary tract cancer: Insights from a multinational cohort treated with cisplatin, gemcitabine, and durvalumab (2025 · European Journal of Cancer · 被引 3)
• Hepatic CD4 T Cells Predict Hepatocellular Carcinoma Risk on Metabolic Dysfunction‐Associated Steatohepatitis Patients (2025 · United European Gastroenterology Journal · 被引 2)
• Clinicogenomic Characterization of Primary Sclerosing Cholangitis–Associated Biliary Tract Cancers (2025 · Clinical Cancer Research · 被引 2)